glucagon in dogs, plasma glucagon and total immunoreactive glucagon (IRG) in response to arginine were determined with antisera specific and non-specific for pancreatic glucagon, respectively.
Only a tiny rise of plasmaa glucagon was observed in the portal vein following arginine infusion performed immediately after total pancreatectomy in a group of 5 normal dogs. In contrast, total IRG in the portal vein increased significantly after arginine infusion even after pancreatectomy.
In alloxan diabetic dogs, arginine infusion after total panereatectomy caused a rise in plasma glucagon in the portal vein, although not significantly.
The response of total IRG to arginine in the portal vein was exaggerated in alloxan diabetic dogs. In a group of one-week post-pancreatecto mized animals, plasma glucagon and total IRG increased significantly in response to arginine infusion.
Furthermore, in these dogs, response of plasma glucagon and plasma total IRG to arginine infusion was abolished after gastrectomy.
From the present results it is concluded that secretion of extrapancreatic glucagon increased in response to arginine infusion in the diabetic state, both alloxan diabetic dogs and one-week post-pancreatectomized dogs. In addition, a rise in extrapancreatic glucagon following arginine infusion in the chronically pan createctomized dogs almost certainly derived from the stomach, as the rise was abolished by gastrectomy. extrapancreatic glucagon; arginine; alloxan diabetic dog; pancreatectomy; gastrectomy
Since an elevation of plasma immunoreactive glucagon, measured with antisera specific for pancreatic glucagon, was demonstrated (Vranic et al. 1974 ; Matsuyama and Foa 1974) , the presence of extrapancreatic forms of glucagon has been established. Morphological studies using the electron microscope or using specific immunofluorescein stains have also identified that the mucosal cells in the gastrointestinal tract of dogs appear to contain a glucagon or true glucagonlike substance Larsson et al. 1975; Baetens et al. 1976) . Although the distribution of extrapancreatic glucagon in the gastrointestinal tract varies in different species (Moody 1972) , a large amount of extrapancreatic glucagon has been demonstrated in the gastric fundus of dogs Larsson et al. 1975; Shima 1976; Munoz-Barragan et al. 1976 ). According to the recent studies, gastric glucagon cannot be distinguished from pancreatic glucagon in view of its immunochemical character, physical property or biological action ). An elevation of fasting plasma glucagon and/or hyperresponsiveness of pancreatic glucagon to arginine have been demonstrated in diabetes mellitus or other diseases (Unger 1974; Seino et al. 1977) . However, it is difficult to identify how much the extrapancreatic glucagon participates in the hyperresponsiveness of plasma immunoreactive glucagon to various stimuli in diabetes mellitus. This is particularly so as no discriminating assay methods are available to distinguish extrapancreatic glucagon from pancreatic glucagon with certainty .
Therefore, in order to clarify the regulation of secretion of extrapancreatic glucagon, plasma glucagon response to arigine was investigated in normal and alloxan diabetic dogs, whose pancreas was acutely removed. Furthermore, glucagon response to arginine was also studied in the dogs , in which both the pancreas and the stomach were removed. 
MATERIALS AND METHODS

DISCUSSION
The base line value of plasma glucagon in the portal vein after total removal of the pancreas remained at a half of the pre-pancreatectomy level in the normal dogs. In addition, the plasma glucagon levels in the portal vein tended to increase approximately 2 hr after total pancreatectomy. Furthermore, the mean level of 270 pg/ml of plasma glucagon was observed in the portal vein of one-week postpancreatectomized animals. These increased levels of plasma glucagon after pan createctomy cannot be attributed to persistence of pancreatic glucagon or crossreacting materials in circulation. These facts indicate the presence of extrapancreatic glucagon and are compatible with the results reported previously (Vranic et al. 1974; Matsuyama et al. 1974; Mashiter et al. 1975) . Furthermore, the present study clearly demonstrates that the base line level of plasma glucagon of extrapancreatic origin increased markedly in one-week post-pancreatectomized animals compared with those of one-hour post-pancreatectomized animals in the normal as well as alloxan diabetic state.
The intravenous administration of arginine has been presumed as one of the most powerful stimuli to the A cells of the pancreatic islets (Ohneda et al. 1972 ). In contrast, extrapancreatic glucagon did not respond to arginine, when the pancreas was intact, since plasma glucagon in the portal vein did not increase remarkably in one-hour post-pancreatectomized animals, as shown in Fig. 1 B. Furthermore, plasma glucagon of extrapancreatic origin responded to arginine infu sion in one-week post-pancreatectomzzed dogs or alloxan diabetic animals, indicat ing an increase in its responsiveness to arginine in a state of insulin deprivation. However, it was suggested that in totally pancreatectomized patients diabetic state is much more important in the responsiveness of extrapancreatic glucagon to arginine infusion than insulin deficiency itself (Barnes and Bloom 1976; Villanueva et al. 1976 ). In fact, the response to arginine of extrapancreatic glucagon was demonstrated more prominently in one-week post-pancreatectomized dogs than alloxan diabetic dogs, in the former the mean level of fasting blood glucose being higher than that of the latter.
On the other hand, clinical observations have demonstrated the elevated re sponse of the A cells in the pancreas to amino acids in diabetes mellitus (Unger et al. 1970; Gossain et al. 1974; Ohneda et al. 1975 ). However, no information is availa ble as to how much extrapancreatic glucagon contributes to hyperglucagonemia observed in diabetes mellitus. The fact that extrapancreatic glucagon responded to arginine infusion in alloxan diabetic dogs, suggests the possible participation of extrapancreatic glucagon in hyperglucagonemia in diabetes mellitus. Distribution of extrapancreatic glucagon, determined by antisera specific for pancreatic glucagon, varies in different species (Larsson et al. 1975; Dobbs et al. 1975; Shima 1976; Villanueva et al. 1976; Holst 1977) . In dogs the stomach is major source of extrapancreatic glucagon Larsson et al. 1975; Shima 1976; . Therefore, to investigate whether gastric glucagon has an important role in the secretion of extrapancreatic glucagon, arginine was administered intravenously prior to and after gastrectomy in one-week postpancreatectomzied animals. Plasma glucagon in the portal vein was reduced markedly after total gastrectomy and glucagon response was abolished . In addition, plasma glucagon did increase in response to arginine in a sham-operated dog, indicating that a failure to increase plasma glucagon after gastrectomy may not be due to manipulation of the upper gastrointestinal tract . Therefore, the results clearly demonstrate that an increase of extrapancreatic glucagon in response to arginine derives mostly from the stomach in such circumstances , as reported previously ). However, the fact that the glucagon level of approximately 100 pg/ml was still observed after gastrectomy, indicates other glucagon-secreting organs than the pancreas and the stomach. Immunoreactive glucagon was detected in the extract from the gastrointestinal tract (Hoist 1977). In addition, it was reported that plasma glucagon was measurable in totally eviscerated rats (Penhos et al. 1975) and recently immunoreactive glucagon was demonstrated in the salivary glands of various species (Lawrence et al . 1976 ). Therefore, those organs might be responsible for a small amount of glucagon in the circulation even after the removal of the pancreas and the stomach .
Somatostatin or insulin suppresses the secretion of extrapancreatic glucagon as well as pancreatic glucagon (Mortimer et al . 1974; Valverde et al. 1975) . Hypergly cemia or insulin-induced hypoglycemia did not affect the secretion of extrapancreatic glucagon ; Ohneda, unpublished observation). In addition , extrapancreatic glucagon responds to arginine only when it is administered to in sulin-deprived animals, as shown in the present study and by others (Mashiter et al . 1975; Blazquez et al. 1976 ) , indicating a difference in the secretion of extrapancreatic glucagon from pancreatic glucagon. In this context, the response of gut glucagonlike immunoreactivity (GLI) was also exaggerated when the pancreas was remo ved both in normal and alloxan diabetic dogs . Therefore, these results suggest that pancreatectomy or insulin deficiency elicits a peculiar circumstance for extrapancreatic glucagon or GIL in the gastrointestinal tract . However, the regulation of extrapancreatic glucagon and its physiological significance still remain to be solved .
